• Lanabecestat (AZD3293): Assay Reliability

  2026-08-12

  A practical, evidence-led guide to using Lanabecestat (AZD3293) in viability, amyloid-beta, and neuronal-function workflows. It explains how SKU BA8438 can support controlled BACE1 inhibition while avoiding common formulation and interpretation errors.

• Norovirus Co-opts NINJ1 for Selective Secretion

  2026-08-12

  The reference study shows that murine norovirus exploits NINJ1-mediated plasma membrane rupture to release the viral protein NS1, while simultaneously permitting broad damage-associated molecular pattern release. By combining CRISPR screening, mechanistic cell biology, viral mutagenesis, and mouse infection models, the authors define a caspase-3– and NINJ1-dependent unconventional secretion pathway with implications for viral immune evasion.

• Phenothiazines Boost Macrophage Antibacterial Defense

  2026-08-11

  The 2025 reference study identifies phenothiazines as host-directed antibacterial lead compounds that strengthen macrophage activity through reactive oxygen species accumulation, lysosomal activation, and autophagy. Inhibitor and scavenger experiments, together with a Salmonella Typhimurium infection model, support a mechanism centered on host-cell defense rather than direct bacterial killing.

• Chlorpromazine HCl in Endocytosis Assays

  2026-08-11

  Chlorpromazine HCl is a practical dopamine receptor antagonist for neuropharmacology studies and a useful pharmacological probe of clathrin-dependent uptake. This guide converts evidence from a Drosophila S2–Spiroplasma model into executable assay design, controls, and troubleshooting strategies while highlighting the limits of pathway-selective interpretation.

• Prochlorperazine-Induced Hemidystonia Mimicking Stroke

  2026-08-10

  The case report Mimicking Acute Stroke describes a pregnant patient whose sudden unilateral weakness and dysarthria triggered an emergency stroke evaluation but were ultimately attributed to prochlorperazine-induced hemidystonia. Its main contribution is diagnostic: evolving orofacial dystonia, medication-history review, rapid response to diphenhydramine, and negative MRI together distinguished a dopamine D2 receptor antagonist adverse effect from acute ischemic stroke.

• Puromycin aminonucleoside: Lab Q&A

  2026-08-09

  A scenario-based guide to using Puromycin aminonucleoside (SKU A3740) in podocyte injury models, cytotoxicity assays, and experimental nephrotic syndrome research. It connects mechanism, assay design, handling, interpretation, and vendor-selection decisions to documented concentration, pH-uptake, solubility, and storage data.

• Sulfaphenazole Optimization for Tuberculosis Therapy

  2026-08-08

  Chen and colleagues optimized sulfaphenazole-derived sulfonamides to retain antimycobacterial activity while reducing CYP 2C9 inhibition, a liability associated with drug–drug interactions. Compound 10d combined a reported MIC of 5.69 μg/mL with CYP 2C9 inhibition above 10 μM, supporting further investigation of sulfonamide-based combination strategies against Mycobacterium tuberculosis.

• Puromycin Aminonucleoside: From Injury to Insight

  2026-08-07

  A translational perspective on how Puromycin aminonucleoside models podocyte injury and nephrotic disease, while emerging insoluble-proteome workflows such as DrPISA may expand mechanistic readouts beyond conventional soluble assays.

• (-)-Blebbistatin: Mechanomemory, Myosin II Inhibition & Cell

  2026-08-07

  Explore the unique role of (-)-Blebbistatin as a non-muscle myosin II inhibitor in mechanomemory research and cytoskeletal dynamics. This in-depth analysis connects latest mechanotransduction findings to practical assay design and advanced cell biology applications.

• Rice Stripe Virus NS3 Manipulates Host Kinase Pathways to Ba

  2026-08-06

  This study uncovers how Rice stripe virus (RSV) NS3 protein exploits the host OsSnRK3.25-OsCBL1/3-OsRBOHF signaling cascade, modulating both viral pathogenicity and transmission through dynamic phosphorylation events. The findings reveal a sophisticated co-survival strategy in virus-vector-plant interactions and suggest broader implications for targeting kinase-mediated signaling in plant pathology.

• METTL17 Regulates Ferroptosis and Tumorigenesis in Colorecta

  2026-08-06

  This study identifies the mitochondrial protein METTL17 as a key regulator of ferroptosis resistance and tumorigenesis in colorectal cancer by modulating mitochondrial RNA methylation and translation. The findings reveal METTL17 as a potential therapeutic target to sensitize colorectal cancer cells to ferroptosis, offering new directions for cancer research focused on mitochondrial function.

• Dutasteride as a Dual 5-Alpha-Reductase Inhibitor: New Front

  2026-08-05

  Explore Dutasteride, a potent dual 5-alpha-reductase inhibitor, and its advanced applications in prostate cancer and apoptosis pathway research. This article delivers a unique focus on apoptosis mechanisms and practical assay optimization, distinguishing it from current literature.

• LPS-Mediated Macrophage Protection: Mechanisms Involving Sys

  2026-08-05

  This study reveals that lipopolysaccharide (LPS) protects macrophages from antitumor drug-induced cytotoxicity by enhancing system Xc−-dependent glutathione synthesis and involving ABCC1-mediated transport. These findings clarify molecular pathways for selective immune cell protection during chemotherapy and inform strategies for mitigating chemotherapy-associated toxicity.

• iMSC-Derived Exosomes Reprogram Macrophage Polarization in I

  2026-08-04

  This study reveals how exosomes from human iPSC-derived mesenchymal stem cells (iMSCs) disrupt the pro-inflammatory cycle between senescent nucleus pulposus (NP) cells and macrophages in intervertebral disc degeneration (IDD). By delivering miR-100-5p and reprogramming macrophage metabolism, these exosomes promote anti-inflammatory states, offering a mechanistic foundation for novel IDD therapies.

• Hexetidine (NSC-17764): Applied Workflows for Oral Infection

  2026-08-04

  Hexetidine (NSC-17764) stands out as a flexible, data-driven antibacterial agent for oral infections, uniquely combining strain-specific efficacy with proven biofilm inhibition. This guide delivers workflow enhancements, troubleshooting strategies, and protocol precision for advanced oral infection research.

14758 records 1/984 page Next 12345 下5页 Last page